We thank Drs Chetty and Serra for their great interest in our article.1 We concluded that patients with intraductal papillary mucinous neoplasms (IPMNs) have a higher risk of developing extrapancreatic neoplasms than those with mucinous cystic neoplasms and pancreatic ductal adenocarcinomas. Our conclusion is not yet definitive owing to the limited number of patients in our study, the rarity of similar reports, and the limitations associated with the retrospective method. However, our conclusions are further supported by similar findings in patients with IPMN.
Kim S, Jang J. Intraductal Papillary Mucinous Neoplasm of the Pancreas and Associated Lesions—Reply. Arch Surg. 2006;141(7):716–717. doi:10.1001/archsurg.141.7.717
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.